Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity.
Tsaousidou E, Chrzanowski J, Drané P, Lee GY, Bahour N, Wang ZB, Deng S, Cao Z, Huang K, He Y, Kaminski M, Michalek D, Güney E, Parmar K, Fendler W, Chowdhury D, Hotamışlıgil GS.
Tsaousidou E, et al. Among authors: fendler w.
Cell Rep. 2024 Jun 25;43(6):114337. doi: 10.1016/j.celrep.2024.114337. Epub 2024 Jun 9.
Cell Rep. 2024.
PMID: 38861384
Free PMC article.